Terug
42
Dagbereik
€ 25,43
€ 26,31
52-Weeksbereik
€ 14,22
€ 30,42
Volume
1.290.764
50D / 200D Gem.
€ 26,27
/
€ 21,87
Vorige Slotkoers
€ 25,82
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 91,1 | 0,3 |
| P/B | 1,4 | 2,9 |
| ROE % | 1,6 | 3,7 |
| Net Margin % | 1,7 | 3,8 |
| Rev Growth 5Y % | 2,0 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 27,22
+4.6%
Low: € 19,00
High: € 35,00
Forward K/W
18,3
Forward WPA
€ 1,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,8 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 1,89
€ 1,87 – € 1,92
|
3,1 B | 1 |
| FY2028 |
€ 1,73
€ 1,16 – € 2,23
|
3 B | 3 |
| FY2027 |
€ 1,56
€ 1,52 – € 1,63
|
2,9 B | 10 |
Belangrijkste Punten
Revenue grew 2,04% annually over 5 years — modest growth
ROE of 1,56% is below average
Generating 230,40M in free cash flow
P/E of 91,06 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,28%
Cash machine — converts 490,21% of earnings into free cash flow
Groei
Revenue Growth (5Y)
2,04%
Revenue (1Y)8,32%
Earnings (1Y)N/A
FCF Growth (3Y)2,92%
Kwaliteit
Return on Equity
1,56%
ROIC3,52%
Net Margin1,73%
Op. Margin8,30%
Veiligheid
Debt / Equity
0,55
Current Ratio2,38
Interest Coverage6,17
Waardering
P/E Ratio
91,06
P/B Ratio1,38
EV/EBITDA21,16
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,32% | Revenue Growth (3Y) | 2,94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,04% | Earnings Growth (5Y) | -39,05% |
| Profitability | |||
| Revenue (TTM) | 2,72B | Net Income (TTM) | 47,00M |
| ROE | 1,56% | ROA | 0,83% |
| Gross Margin | 55,02% | Operating Margin | 8,30% |
| Net Margin | 1,73% | Free Cash Flow (TTM) | 230,40M |
| ROIC | 3,52% | FCF Growth (3Y) | 2,92% |
| Safety | |||
| Debt / Equity | 0,55 | Current Ratio | 2,38 |
| Interest Coverage | 6,17 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 91,06 | P/B Ratio | 1,38 |
| P/S Ratio | 1,57 | PEG Ratio | -0,74 |
| EV/EBITDA | 21,16 | Dividend Yield | 0,00% |
| Market Cap | 4,28B | Enterprise Value | 4,78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,72B | 2,51B | 2,57B | 2,57B | 2,51B |
| Net Income | 47,00M | -1,12B | -100,20M | 243,10M | 340,50M |
| EPS (Diluted) | 0,28 | -6,50 | -0,60 | 1,34 | 1,48 |
| Gross Profit | 1,50B | 1,39B | 1,45B | 1,49B | 1,46B |
| Operating Income | 225,70M | -1,04B | 31,50M | 319,20M | 306,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,68B | 5,35B | 6,61B | 6,59B | 6,57B |
| Total Liabilities | 2,57B | 2,42B | 2,43B | 2,38B | 2,52B |
| Shareholders' Equity | 3,11B | 2,93B | 4,17B | 4,21B | 4,06B |
| Total Debt | 1,71B | 1,55B | 1,65B | 1,53B | 1,48B |
| Cash & Equivalents | 1,21B | 1,07B | 940,00M | 606,90M | 1,07B |
| Current Assets | 2,03B | 1,79B | 1,74B | 1,42B | 1,84B |
| Current Liabilities | 852,60M | 878,70M | 780,80M | 1,24B | 1,21B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#595 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026